Back to Search Start Over

The BDNFVal66MetSNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer’s disease

Authors :
Franzmeier, Nicolai
Ren, Jinyi
Damm, Alexander
Monté-Rubio, Gemma
Boada, Mercè
Ruiz, Agustín
Ramirez, Alfredo
Jessen, Frank
Düzel, Emrah
Rodríguez Gómez, Octavio
Benzinger, Tammie
Goate, Alison
Karch, Celeste M.
Fagan, Anne M.
McDade, Eric
Buerger, Katharina
Levin, Johannes
Duering, Marco
Dichgans, Martin
Suárez-Calvet, Marc
Haass, Christian
Gordon, Brian A.
Lim, Yen Ying
Masters, Colin L.
Janowitz, Daniel
Catak, Cihan
Wolfsgruber, Steffen
Wagner, Michael
Milz, Esther
Moreno-Grau, Sonia
Teipel, Stefan
Grothe, Michel J
Kilimann, Ingo
Rossor, Martin
Fox, Nick
Laske, Christoph
Chhatwal, Jasmeer
Falkai, Peter
Perneczky, Robert
Lee, Jae-Hong
Spottke, Annika
Boecker, Henning
Brosseron, Frederic
Fliessbach, Klaus
Heneka, Michael T.
Nestor, Peter
Peters, Oliver
Fuentes, Manuel
Menne, Felix
Priller, Josef
Spruth, Eike J.
Franke, Christiana
Schneider, Anja
Westerteicher, Christine
Speck, Oliver
Wiltfang, Jens
Bartels, Claudia
Araque Caballero, Miguel Ángel
Metzger, Coraline
Bittner, Daniel
Salloway, Stephen
Danek, Adrian
Hassenstab, Jason
Yakushev, Igor
Schofield, Peter R.
Morris, John C.
Bateman, Randall J.
Ewers, Michael
Source :
Molecular Psychiatry; February 2021, Vol. 26 Issue: 2 p614-628, 15p
Publication Year :
2021

Abstract

In Alzheimer’s disease (AD), a single-nucleotide polymorphism in the gene encoding brain-derived neurotrophic factor (BDNFVal66Met) is associated with worse impact of primary AD pathology (beta-amyloid, Aß) on neurodegeneration and cognitive decline, rendering BDNFVal66Metan important modulating factor of cognitive impairment in AD. However, the effect of BDNFVal66Meton functional networks that may underlie cognitive impairment in AD is poorly understood. Using a cross-validation approach, we first explored in subjects with autosomal dominant AD (ADAD) from the Dominantly Inherited Alzheimer Network (DIAN) the effect of BDNFVal66Meton resting-state fMRI assessed functional networks. In seed-based connectivity analysis of six major large-scale networks, we found a stronger decrease of hippocampus (seed) to medial-frontal connectivity in the BDNFVal66Metcarriers compared to BDNFValhomozogytes. BDNFVal66Metwas not associated with connectivity in any other networks. Next, we tested whether the finding of more pronounced decrease in hippocampal-medial-frontal connectivity in BDNFVal66Metcould be also found in elderly subjects with sporadically occurring Aß, including a group with subjective cognitive decline (N?=?149, FACEHBI study) and a group ranging from preclinical to AD dementia (N?=?114, DELCODE study). In both of these independently recruited groups, BDNFVal66Metwas associated with a stronger effect of more abnormal Aß-levels (assessed by biofluid-assay or amyloid-PET) on hippocampal-medial-frontal connectivity decreases, controlled for hippocampus volume and other confounds. Lower hippocampal-medial-frontal connectivity was associated with lower global cognitive performance in the DIAN and DELCODE studies. Together these results suggest that BDNFVal66Metis selectively associated with a higher vulnerability of hippocampus-frontal connectivity to primary AD pathology, resulting in greater AD-related cognitive impairment.

Details

Language :
English
ISSN :
13594184 and 14765578
Volume :
26
Issue :
2
Database :
Supplemental Index
Journal :
Molecular Psychiatry
Publication Type :
Periodical
Accession number :
ejs49618934
Full Text :
https://doi.org/10.1038/s41380-019-0404-6